Description
Xcel Pharma XCEL – RIP 2.5 contains Human Growth Hormone Fragment 177–199 (HGH Frag), a peptide fragment derived from the C-terminal region of human growth hormone. It is primarily discussed in research involving growth-hormone-related signaling and metabolic pathways.
Each vial contains 2.5 mg of the peptide, with the product supplied as a five-vial pack along with bacteriostatic water ampoules.
Benefits
- Contains Human Growth Hormone Fragment 177–199
- Derived from the C-terminal portion of human growth hormone
- Studied in research involving metabolic pathways
- Commonly researched in relation to lipid and body-composition mechanisms
- Convenient 2.5 mg vial presentation
- Five-vial pack
- Includes bacteriostatic water ampoules
- Manufactured under the Xcel Pharma brand
Product Overview
Xcel Pharma XCEL – RIP 2.5 contains HGH Fragment 177–199, a modified peptide fragment corresponding to residues 177 through 199 of human growth hormone.
Unlike full-length HGH, this fragment does not represent the complete 191-amino-acid growth hormone molecule. It has attracted research interest because of its potential relationship with metabolic and lipid-related pathways.
Research surrounding HGH fragments remains considerably more limited than the evidence available for approved growth-hormone therapies. Therefore, claims about fat loss, muscle growth, or other bodybuilding outcomes should not be treated as established medical effects.
Product Composition
- Active Compound: Human Growth Hormone Fragment 177–199
- Potency: 2.5 mg/vial
- Form: Lyophilized peptide
- Pack: 2.5 mg vial × 5 vials
- Bacteriostatic Water: 2 mL × 5 ampoules
- Packaging: Security seal label and packed box
- Brand: Xcel Pharma
Product Details
XCEL – RIP 2.5 is supplied as a five-vial research peptide pack, with each vial containing 2.5 mg of Human Growth Hormone Fragment 177–199. The package also includes five 2 mL bacteriostatic water ampoules for product preparation.
Reviews
There are no reviews yet.